The association between famotidine and in‐hospital mortality of patients with COVID‐19
et al., Journal of Medical Virology,
PSM retrospective 9,565 COVID-19 hospitalized patients in the USA, 1,593 receiving famotidine, showing no significant difference in mortality.
risk of death, no change, OR 1.00, p = 0.97, treatment 1,593, control 7,972, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Kuno et al., 10/11/2021, retrospective, propensity score matching, USA, North America, peer-reviewed, 4 authors, study period 1 March, 2020 - 30 March, 2021.